NasdaqGS - Nasdaq Real Time Price USD
Sotera Health Company (SHC)
13.36
-0.14
(-1.00%)
As of 12:18:40 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,106,788
1,100,441
1,049,288
1,003,687
931,478
Cost of Revenue
496,176
498,146
472,130
446,683
412,806
Gross Profit
610,612
602,295
577,158
557,004
518,672
Operating Expense
309,116
304,669
300,466
308,654
261,939
Operating Income
301,496
297,626
276,692
248,350
256,733
Net Non Operating Interest Income Expense
-163,796
-164,691
-142,878
-80,144
-74,192
Other Income Expense
-49,663
-19,061
-27,787
-411,317
-6,825
Pretax Income
88,037
113,874
106,027
-243,111
175,716
Tax Provision
63,222
69,476
54,651
-9,541
58,595
Net Income Common Stockholders
24,837
44,398
51,376
-233,570
116,882
Diluted NI Available to Com Stockholders
24,837
44,398
51,376
-233,570
116,882
Basic EPS
0.09
0.16
0.18
-0.83
0.41
Diluted EPS
0.09
0.16
0.18
-0.83
0.41
Basic Average Shares
283,195.25
282,784
281,008
280,096
279,228
Diluted Average Shares
284,780
284,906
283,222
280,096
279,382
Total Operating Income as Reported
--
297,626
276,692
248,350
256,733
Total Expenses
805,292
802,815
772,596
755,337
674,745
Net Income from Continuing & Discontinued Operation
24,815
44,398
51,376
-233,570
116,882
Normalized Income
58,517.60
63,647.93
79,151.61
167,792.90
131,563.12
Interest Expense
163,796
164,691
142,878
80,144
74,192
Net Interest Income
-163,796
-164,691
-142,878
-80,144
-74,192
EBIT
251,833
278,565
248,905
-162,967
249,908
EBITDA
415,844
442,202
406,830
-17,413
400,810
Reconciled Cost of Revenue
393,799
396,548
378,004
364,069
325,685
Reconciled Depreciation
164,011
163,637
157,925
145,554
150,902
Net Income from Continuing Operation Net Minority Interest
24,815
44,398
51,376
-233,570
116,882
Total Unusual Items Excluding Goodwill
-56,171
-24,367
-35,159
-417,758
-22,026
Total Unusual Items
-56,171
-24,367
-35,159
-417,758
-22,026
Normalized EBITDA
472,015
466,569
441,989
400,345
422,836
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-22,468.40
-5,117.07
-7,383.39
-16,395.10
-7,344.88
12/31/2021 - 11/20/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTD Mettler-Toledo International Inc.
1,183.03
+0.72%
LH Labcorp Holdings Inc.
250.27
-0.27%
MYGN Myriad Genetics, Inc.
4.1250
-2.94%
QGEN Qiagen N.V.
42.51
-1.05%
TELO.V Telo Genomics Corp.
0.0800
-11.11%
TMO.NE Thermo Fisher Scientific Inc.
15.90
-0.31%
GENE Genetic Technologies Limited
0.7650
0.00%
IQV IQVIA Holdings Inc.
152.49
-2.33%
GH Guardant Health, Inc.
41.40
-0.62%
RNVA Rennova Health, Inc.
0.0001
0.00%